February 2017
* New European research project B-SMART targets RNA-based nanomedicines against Alzheimer’s and spinal and bulbar muscular atrophy (SBMA)
* Innovative nanotechnological RNA delivery systems to provide first causal therapy approach
* B-SMART unites internationally renowned experts from 9 academic institutions and industrial partners coordinated by the University Medical Center Utrecht
* The European Commission invests €6 million over the next five years。

病友黑龙江-阿米其检索到一个最新消息。欧盟委员会从今年元月1日开始执行一个新的研究计划，主要针对两种疾病：老年痴呆症（阿尔兹海默症）和肯尼迪病开展名为B-SMART的研究计划，组织荷兰，西班牙，比利时，英国，意大利，挪威和德国七个国家的9个研究机构专家共同研究基于RNA的纳米药物治疗的研究。在五年内投资600万欧元。